186 related articles for article (PubMed ID: 15099376)
1. In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases.
Hesling C; D'Incan M; Mansard S; Franck F; Corbin-Duval A; Chèvenet C; Déchelotte P; Madelmont JC; Veyre A; Souteyrand P; Bignon YJ
Br J Dermatol; 2004 Apr; 150(4):761-7. PubMed ID: 15099376
[TBL] [Abstract][Full Text] [Related]
2. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
Miller AK; Dusing R; Meggison A; Aires D
J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
[TBL] [Abstract][Full Text] [Related]
3. [Topical treatment of melanoma skin metastases with imiquimod].
Sigüenza M; Pizarro A; Mayor M; Vidaurrázaga C; Miralles L; González-Beato M; Casado M
Actas Dermosifiliogr; 2005 Mar; 96(2):111-5. PubMed ID: 16476347
[TBL] [Abstract][Full Text] [Related]
4. [In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
Elfatoiki FZ; Longvert C; Clerici T; Bourgault-Villada I; Roudier-Pujol C; Vasseur E; Saiag P
Ann Dermatol Venereol; 2014 Feb; 141(2):106-10. PubMed ID: 24507204
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma.
Bong AB; Bonnekoh B; Franke I; Schön M; Ulrich J; Gollnick H
Dermatology; 2002; 205(2):135-8. PubMed ID: 12218228
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of BRCA1 in A375 melanoma cell line increases radio-sensitivity and modifies metastatic and angiogenic gene expression.
Hesling C; D'Incan M; D'Incan C; Souteyrand P; Monboisse JC; Pasco S; Madelmont JC; Bignon YJ
J Invest Dermatol; 2004 Feb; 122(2):369-80. PubMed ID: 15009718
[TBL] [Abstract][Full Text] [Related]
7. Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells.
Savarese I; Papi F; D'Errico A; Gori A; Grazzini M; Vannucchi M; Massi D; De Giorgi V
Clin Exp Dermatol; 2015 Jan; 40(1):27-30. PubMed ID: 25252087
[TBL] [Abstract][Full Text] [Related]
8. Clearance of invasive melanoma with topical imiquimod.
Moon SD; Spencer JM
J Drugs Dermatol; 2013 Jan; 12(1):107-8. PubMed ID: 23377337
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
Ray CM; Kluk M; Grin CM; Grant-Kels JM
Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
[TBL] [Abstract][Full Text] [Related]
10. Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod.
Schön MP; Wienrich BG; Drewniok C; Bong AB; Eberle J; Geilen CC; Gollnick H; Schön M
J Invest Dermatol; 2004 May; 122(5):1266-76. PubMed ID: 15140231
[TBL] [Abstract][Full Text] [Related]
11. Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature.
Ellis LZ; Cohen JL; High W; Stewart L
Dermatol Surg; 2012 Jun; 38(6):937-46. PubMed ID: 22338583
[TBL] [Abstract][Full Text] [Related]
12. [Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil].
Florin V; Vercambre-Darras S; Piette F; Mortier L
Ann Dermatol Venereol; 2008; 135(8-9):603-4. PubMed ID: 18789300
[No Abstract] [Full Text] [Related]
13. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
[TBL] [Abstract][Full Text] [Related]
14. Using topical imiquimod for the management of positive in situ margins after melanoma resection.
Pandit AS; Geiger EJ; Ariyan S; Narayan D; Choi JN
Cancer Med; 2015 Apr; 4(4):507-12. PubMed ID: 25620351
[TBL] [Abstract][Full Text] [Related]
15. [Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases].
Loquai C; Nashan D; Metze D; Beiteke U; Rüping KW; Luger TA; Grabbe S
Hautarzt; 2004 Feb; 55(2):176-81. PubMed ID: 14968329
[TBL] [Abstract][Full Text] [Related]
16. Topical imiquimod in the treatment of metastatic melanoma to skin.
Wolf IH; Smolle J; Binder B; Cerroni L; Richtig E; Kerl H
Arch Dermatol; 2003 Mar; 139(3):273-6. PubMed ID: 12622616
[No Abstract] [Full Text] [Related]
17. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
Muñoz CM; Sánchez JL; Martín-García RF
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1543-5. PubMed ID: 15606836
[TBL] [Abstract][Full Text] [Related]
18. Topically applied imiquimod inhibits vascular tumor growth in vivo.
Sidbury R; Neuschler N; Neuschler E; Sun P; Wang XQ; Miller R; Tomai M; Puscasiu E; Gugneja S; Paller AS
J Invest Dermatol; 2003 Nov; 121(5):1205-9. PubMed ID: 14708627
[TBL] [Abstract][Full Text] [Related]
19. Topical imiquimod in the treatment of two cutaneous melanocytomas in a dog.
Coyner K; Loeffler D
Vet Dermatol; 2012 Apr; 23(2):145-9, e31. PubMed ID: 21777307
[TBL] [Abstract][Full Text] [Related]
20. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
